The DNA base sequence of the pI promoter of the lambda-related phage 21 will be
determined. We have already sequenced pI from phage 434. Phage 21 is of
interest because, unlike 434, it has a different insertion site than lambda.
However, its pI promoter responds to the cII protein. Mutations in the pI
promoter of lambda will be identified and sequenced.
The structural gene for biotin sulfoxide reductase (bisC) will be cloned on a
multi-copy plasmid. This should provide us with sufficient bisC protein to
obtain a pure product, as well as facilitating genetic analysis. Insertions of
Mu Ap 1ac in bisC will be selected so that the regulation, if any, of bisC can
be examined. We have found that this enzyme uses the same molybdenum cofactor
(product of genes ch1A, ch1B, ch1E, ch1G) as nitrate reductase. The relation of
those genes to bisC regulation will be tested.
The birA gene, structural gene for the bifunctional protein
holoenzyme-synthetase biotin-repressor, already cloned as a 2.1 kb segment, will
be sequenced in wild type and mutant form.
National Institute of Allergy and Infectious Diseases
CFDA Code
DUNS Number
009214214
UEI
HJD6G4D6TJY5
Project Start Date
01-June-1978
Project End Date
31-May-1988
Budget Start Date
01-June-1986
Budget End Date
31-May-1987
Project Funding Information for 1986
Total Funding
$268,188
Direct Costs
$158,691
Indirect Costs
$109,497
Year
Funding IC
FY Total Cost by IC
1986
National Institute of Allergy and Infectious Diseases
$268,188
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01AI008573-19
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01AI008573-19
Patents
No Patents information available for 5R01AI008573-19
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01AI008573-19
Clinical Studies
No Clinical Studies information available for 5R01AI008573-19
News and More
Related News Releases
No news release information available for 5R01AI008573-19
History
No Historical information available for 5R01AI008573-19
Similar Projects
No Similar Projects information available for 5R01AI008573-19